2013
DOI: 10.1016/j.athoracsur.2013.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Methylprednisolone in Neonatal Cardiac Surgery: Reduced Inflammation Without Improved Clinical Outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
75
1
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(85 citation statements)
references
References 24 publications
8
75
1
1
Order By: Relevance
“…Their results are conflictive with some trials reporting benefit [8,11,19,21] while others reporting no effect on clinical outcomes [7,9,13,20]. The results of an ongoing trial on 190 neonates are still awaited and hopefully will give us more information [22].…”
Section: Less Inflammation Better Clinical Outcomes?mentioning
confidence: 88%
See 1 more Smart Citation
“…Their results are conflictive with some trials reporting benefit [8,11,19,21] while others reporting no effect on clinical outcomes [7,9,13,20]. The results of an ongoing trial on 190 neonates are still awaited and hopefully will give us more information [22].…”
Section: Less Inflammation Better Clinical Outcomes?mentioning
confidence: 88%
“…Some studies found that steroids can blunt inflammation [7][8][9][10][11][12][13][14] while others found the opposite [15]. Most importantly, it is unclear to what degree this presumed Banti-inflammatoryê ffect also translates into better clinical outcomes [7,10,13]. Firstly, it is very difficult to characterise the multifaceted nature of the SIRS response whereby a variety of cytokines are activated and interact in a rather complex, unpredictable manner [16].…”
Section: Less Inflammation Better Clinical Outcomes?mentioning
confidence: 99%
“…One study has suggested that giving a single dose of MP (15 mg/kg) before a cardiopulmonary bypass surgery resulted in an improved myocardial function (32). In the neonatal period, a 30 mg/kg single dose of MP prior to open heart surgery reduced systemic infl ammatory responses and was shown to be cardioprotective (33). In our study, after an application with a high-dose of MP in the early period after BCT it was continued with low-dose steroid therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Steroids are known to prevent apoptosis subsequent to myocardial ischemia by increasing the expression of Bcl (6). Steroids act as anti-infl ammatory agents through the reduction of early infl ammatory processes and have also been shown to be cardioprotective in myocardial injury associated with ischemia and cardiac surgery (32,33). One study has suggested that giving a single dose of MP (15 mg/kg) before a cardiopulmonary bypass surgery resulted in an improved myocardial function (32).…”
Section: Discussionmentioning
confidence: 99%
“…3 Corticosteroid prophylaxis in heart surgery has been studied for several years, however its role remains controversial. [4][5][6][7][8] Several mechanisms of corticosteroid's benefit on patient who required cardiopulmonary bypass have been shown on prior studies. They may include reduction in the expression of endothelial molecule, improvement in myocardial and pulmonary cell integrity, cytokine release, and complement activation.…”
Section: Introductionmentioning
confidence: 99%